Intuitive Surgical EBITDA 2010-2024 | ISRG
Intuitive Surgical annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Intuitive Surgical EBITDA for the quarter ending September 30, 2024 was $0.703B, a 20.75% increase year-over-year.
- Intuitive Surgical EBITDA for the twelve months ending September 30, 2024 was $2.569B, a 18.33% increase year-over-year.
- Intuitive Surgical 2023 annual EBITDA was $2.229B, a 10.42% increase from 2022.
- Intuitive Surgical 2022 annual EBITDA was $2.019B, a 6.72% decline from 2021.
- Intuitive Surgical 2021 annual EBITDA was $2.164B, a 61.1% increase from 2020.
| Intuitive Surgical Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $2,229 |
| 2022 | $2,019 |
| 2021 | $2,164 |
| 2020 | $1,343 |
| 2019 | $1,591 |
| 2018 | $1,333 |
| 2017 | $1,173 |
| 2016 | $1,052 |
| 2015 | $856 |
| 2014 | $653 |
| 2013 | $957 |
| 2012 | $936 |
| 2011 | $764 |
| 2010 | $613 |
| 2009 | $412 |
| Intuitive Surgical Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $703 |
| 2024-06-30 | $688 |
| 2024-03-31 | $587 |
| 2023-12-31 | $591 |
| 2023-09-30 | $582 |
| 2023-06-30 | $568 |
| 2023-03-31 | $488 |
| 2022-12-31 | $534 |
| 2022-09-30 | $496 |
| 2022-06-30 | $491 |
| 2022-03-31 | $499 |
| 2021-12-31 | $548 |
| 2021-09-30 | $530 |
| 2021-06-30 | $592 |
| 2021-03-31 | $493 |
| 2020-12-31 | $500 |
| 2020-09-30 | $344 |
| 2020-06-30 | $148 |
| 2020-03-31 | $351 |
| 2019-12-31 | $465 |
| 2019-09-30 | $420 |
| 2019-06-30 | $410 |
| 2019-03-31 | $295 |
| 2018-12-31 | $368 |
| 2018-09-30 | $350 |
| 2018-06-30 | $305 |
| 2018-03-31 | $310 |
| 2017-12-31 | $359 |
| 2017-09-30 | $308 |
| 2017-06-30 | $281 |
| 2017-03-31 | $225 |
| 2016-12-31 | $277 |
| 2016-09-30 | $288 |
| 2016-06-30 | $277 |
| 2016-03-31 | $211 |
| 2015-12-31 | $278 |
| 2015-09-30 | $232 |
| 2015-06-30 | $195 |
| 2015-03-31 | $151 |
| 2014-12-31 | $240 |
| 2014-09-30 | $179 |
| 2014-06-30 | $160 |
| 2014-03-31 | $74 |
| 2013-12-31 | $235 |
| 2013-09-30 | $199 |
| 2013-06-30 | $246 |
| 2013-03-31 | $277 |
| 2012-12-31 | $240 |
| 2012-09-30 | $235 |
| 2012-06-30 | $247 |
| 2012-03-31 | $214 |
| 2011-12-31 | $219 |
| 2011-09-30 | $196 |
| 2011-06-30 | $184 |
| 2011-03-31 | $165 |
| 2010-12-31 | $182 |
| 2010-09-30 | $142 |
| 2010-06-30 | $150 |
| 2010-03-31 | $139 |
| 2009-12-31 | $137 |
| 2009-09-30 | $113 |
| 2009-06-30 | $109 |
| 2009-03-31 | $53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $211.086B | $7.124B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |